The nature of electrical remodeling in a canine model of ischemic cardiomyopathy (ICM; induced by repetitive intracoronary microembolizations) that exhibits spontaneous ventricular tachycardia is not entirely clear. We used the patch-clamp technique to record action potentials and ionic currents of left ventricular myocytes isolated from the region affected by microembolizations. We also used the immunoblot technique to examine channel subunit expression in adjacent affected tissue. Ventricular myocytes and tissue isolated from the corresponding region of normal hearts served as control. ICM myocytes had prolonged action potential duration (APD) and more pronounced APD dispersion. Slow delayed rectifier current (I Ks) was reduced at voltages positive to 0 mV, along with a negative shift in its voltage dependence of activation. Immunoblots showed that there was no change in KCNQ1.1 (IKs pore-forming or ␣-subunit), but KCNE1 (IKs auxiliary or ␤-subunit) was reduced, and KCNQ1.2 (a truncated KCNQ1 splice variant with a dominant-negative effect on IKs) was increased. Transient outward current (I to) was reduced, along with an acceleration of the slow phase of recovery from inactivation. Immunoblots showed that there was no change in Kv4.3 (␣-subunit of fast-recovering Ito component), but KChIP2 (␤-subunit of fast-recovering component) and Kv1.4 (␣-subunit of slow-recovering component) were reduced. Inward rectifier current was reduced. L-type Ca current was unaltered. The immunoblot data provide mechanistic insights into the observed changes in current amplitude and gating kinetics of IKs and Ito. We suggest that these changes, along with the decrease in inward rectifier current, contribute to APD prolongation in ICM hearts. heart failure; arrhythmia; voltage clamp; oocyte expression HEART FAILURE (HF) IS PREVALENT in the Western world and will become more so as the population ages. About 50% of HF patients succumb to sudden death, most of which likely results from malignant ventricular arrhythmias (54). Although implantable cardioverter/defibrillators can save lives, the high costs prevent them from being available to the majority of HF patients. Pharmacological interventions are the practical approach. A prerequisite for the design of preventive medicine is the knowledge about arrhythmogenic mechanisms in HF patients, based on which potential targets can be identified and explored.
The nature of electrical remodeling in a canine model of ischemic cardiomyopathy (ICM; induced by repetitive intracoronary microembolizations) that exhibits spontaneous ventricular tachycardia is not entirely clear. We used the patch-clamp technique to record action potentials and ionic currents of left ventricular myocytes isolated from the region affected by microembolizations. We also used the immunoblot technique to examine channel subunit expression in adjacent affected tissue. Ventricular myocytes and tissue isolated from the corresponding region of normal hearts served as control. ICM myocytes had prolonged action potential duration (APD) and more pronounced APD dispersion. Slow delayed rectifier current (I Ks) was reduced at voltages positive to 0 mV, along with a negative shift in its voltage dependence of activation. Immunoblots showed that there was no change in KCNQ1.1 (IKs pore-forming or ␣-subunit), but KCNE1 (IKs auxiliary or ␤-subunit) was reduced, and KCNQ1.2 (a truncated KCNQ1 splice variant with a dominant-negative effect on IKs) was increased. Transient outward current (I to) was reduced, along with an acceleration of the slow phase of recovery from inactivation. Immunoblots showed that there was no change in Kv4.3 (␣-subunit of fast-recovering Ito component), but KChIP2 (␤-subunit of fast-recovering component) and Kv1.4 (␣-subunit of slow-recovering component) were reduced. Inward rectifier current was reduced. L-type Ca current was unaltered. The immunoblot data provide mechanistic insights into the observed changes in current amplitude and gating kinetics of IKs and Ito. We suggest that these changes, along with the decrease in inward rectifier current, contribute to APD prolongation in ICM hearts. heart failure; arrhythmia; voltage clamp; oocyte expression HEART FAILURE (HF) IS PREVALENT in the Western world and will become more so as the population ages. About 50% of HF patients succumb to sudden death, most of which likely results from malignant ventricular arrhythmias (54) . Although implantable cardioverter/defibrillators can save lives, the high costs prevent them from being available to the majority of HF patients. Pharmacological interventions are the practical approach. A prerequisite for the design of preventive medicine is the knowledge about arrhythmogenic mechanisms in HF patients, based on which potential targets can be identified and explored.
There have been intensive research efforts to study structural and functional changes (remodeling) that take place in failing hearts, using animal models as well as patient heart samples (2, 16, 31) . In terms of arrhythmogenic mechanisms, two common changes have been identified in failing hearts of animals and humans of different etiologies: 1) prolongation of action potential duration (APD), and 2) abnormalities in intracellular Ca (Ca i ) handling (2, 5, 54) . The latter include slower release as well as slower reuptake of Ca i by the sarcoplasmic reticulum and elevation of diastolic Ca i level (2, 5, 29, 54) . APD prolongation, in conjunction with abnormalities in Ca i handling, increases the risk for delayed and early afterdepolarizations, which can lead to triggered arrhythmias (16) . Furthermore, to maintain proper action potential configurations and durations in different regions of the heart, cardiac myocytes need to maintain a delicate balance between inward and outward currents in a region-specific manner (34) . A disturbance in the repolarization process can often lead to an excessive dispersion of APD. When this occurs, especially in conjunction with a slowing of impulse conduction [due to partial depolarization of the resting membrane potential (RMP), interstitial fibrosis, or dysfunctional gap junction channels], the stage is set for reentrant arrhythmias (16) . Therefore, preventing or correcting ventricular APD prolongation is a key factor in the design of pharmacological interventions to protect HF patients at risk for ventricular arrhythmias.
It is not entirely clear what causes APD prolongation in failing hearts (16) . Although a reduction in the transient outward current (I to ) is almost a universal finding in ventricular myocytes from HF animals and patients (2, 5, 31, 54) , a decrease in I to per se does not necessarily lead to APD prolongation (except in rodents) (14, 22, 33) . In large animals and humans, I to is directly responsible for phase 1 repolarization only. By setting the rate of phase 1 repolarization and the voltage reached at the end of phase 1, I to can indirectly affect the degree of activation and amplitudes of other plateau currents, notably the L-type Ca channel current (I CaL ) (14) . Inhibiting I to by 4-aminopyridine can lead to APD prolongation (13) , little change (12), or shortening (23) , although the specificity of 4-aminopyridine is an issue (32, 42) . Computer simulations suggest that reducing I to either has a minimal effect on APD (40), or shortens APD by shifting phase 1 voltage in the positive direction and secondarily reducing the I CaL amplitude (14) . Computer simulation of action potentials and currents in human HF suggests that a putative decrease in the rapid delayed rectifier current (I Kr ) and/or the slow delayed rectifier current (I Ks ) is necessary to account for APD prolongation (40) . However, data on I Kr and I Ks in failing hearts are rare from animal studies (25) and even more so for HF patients (24) .
Sabbah et al. (48) developed a canine HF model due to ischemic cardiomyopathy (ICM) induced by repetitive intracoronary microembolizations. This model exhibits features resembling those of clinical ICM: a progressive decline of left ventricular (LV) systolic function, interstitial fibrosis, an increase in serum catecholamines, and, importantly for the discussion of arrhythmogenesis in HF, spontaneous ventricular tachycardia (VT) (39, 46) . At the cellular level, ventricular myocytes from the ICM dog hearts manifest APD prolongation (59) . It has been shown that one contributing factor to APD prolongation in these ICM cells is an increase in the longlasting component of TTX-sensitive Na channel current (59, 62) . However, there have been no investigations into other ion channels involved in determining the action potential configuration and duration. These include I Kr , I Ks , I to , inward rectifier current (I K1 ), and I CaL .
We have followed the protocol developed by Sabbah et al. to create the canine model of ICM and use it to probe the cause(s) for APD prolongation. Previously, our laboratory has reported the surprising finding that ventricular myocytes from these ICM dogs had a larger I Kr current density than myocytes from the corresponding region of control dogs (21) . This may be a mechanism to protect these hearts from further excessive APD prolongation. At the molecular level, there was no marked change in the protein level of the I Kr pore-forming component, ERG1 (21, 50) . On the other hand, there was a marked reduction in the immunoreactivity to an antibody (Ab) (Alomone) specific for KCNE2, the putative auxiliary subunit of I Kr (1, 21) . We attributed the increase of I Kr in ICM myocytes to a relief of KCNE2's suppressing effect on currents through the ERG1 channel (30) . In the present study, we report changes in the other currents involved in shaping the action potential plateau phase (I Ks , I to , I K1 , and I CaL ) in LV myocytes from these ICM dogs. We also present immunoblot data that provide insights into possible mechanisms underlying the observed changes in current amplitude and gating kinetics.
MATERIALS AND METHODS

Canine Intracoronary Microembolizations
The animal protocol was reviewed and approved by Institutional Animal Care and Use Committee of Virginia Commonwealth University. The procedure was similar to that developed by Sabbah et al. (48) . Briefly, five mongrel dogs (male, 23-27 kg) were subjected to intracoronary injections of polystyrene latex microspheres (diameter 77-102 m, Polysciences, Warrington, PA). Beads (2-4 ϫ 10 4 ) in 0.5-1 ml volume were injected via cardiac catheterization under general anesthesia and sterile conditions. Each dog received a total of two to four injections, alternating between left anterior descending coronary artery and left first circumflex coronary artery once every 3-4 wk until the LV ejection fraction (LVEF) dropped to Յ35%.
Approximately 3 months after the final microsphere injection, dogs were subjected to hemodynamic measurements. The hearts were harvested, and a wedge of LV free wall (vascular bed of the first circumflex coronary artery) was dissected out for single-cell isolation (see below). A transmural section of anterior LV free wall containing interstitial fibrosis was dissected for histological analysis. Tissue chunks from LV apex were snap frozen in liquid nitrogen and stored at Ϫ80°C for immunoblot analysis. Corresponding areas of five normal canine hearts were dissected in the same manner for control experiments. The distance between the origin of cell isolation and regions for histology or immunoblot analysis ranged from 0.3 to 1 cm or 0.5 to 2 cm, respectively.
Single-Cell Preparation
This procedure was modified from a method described before (56) . The first circumflex coronary artery was cannulated. Epicardial and intramural vascular openings were ligated to ensure good perfusion. The tissue was mounted on a Langendorff apparatus and perfused with warm (36°C), oxygenated Tyrode solution (composition given below) for 2-4 min. The perfusate was then switched to a nominally Ca-free Tyrode containing bovine serum albumin (BSA, 0.5 mg/ml) for 6 -7 min. Then the tissue was perfused with a collagenasecontaining solution (type II, Worthington, 0.5 mg/ml) for 25-30 min until the tissue was softened. After collagenase digestion, the midmyocardial layer (ϳ0.2 cm away from both the epicardial and endocardial surfaces) was isolated and minced. The small tissue chunks were returned to fresh collagenase-containing solution and gently shaken in a 36°C water bath for 10 -15 min. The cell suspension was collected, and cells formed sediment by gravity. The remaining tissue chunks were subjected to further trituration in fresh collagenase solution for four to six more times. Cell sediments were resuspended in a Tyrode solution containing (in mM) 0.5 Ca, 10 taurine, 10 mannitol, and 10 pyruvate, and stored at room temperature. Some cells were plated in serum-free DMEM and stored in a 36°C 5% CO 2 moist incubator. Cells stored under both conditions were used within 10 h after isolation. No differences in terms of membrane action potential or currents were noticed between cells stored under these two conditions, and the data were pooled.
Patch-Clamp Recordings
Cells were plated on a poly-L-lysine coated coverslip placed in a tissue bath mounted on the stage of an inverted Nikon microscope and continuously superfused with bath solution maintained at 33-34°C. Membrane voltage and currents were recorded using the whole-cell variant of the patch-clamp technique, with AxoPatch 1D or AxoPatch200 in current-clamp and voltage-clamp mode, respectively. The pipette had a tip resistance of 1-2 M⍀, and 95% of series resistance was compensated. Experiments were controlled by pClamp6. Currents were low-pass filtered at 1 kHz (Frequency Devices), and data were stored for offline analysis.
The pipette solution contained (in mM) 125 potassium-aspartate, 20 KCl, 10 potassium-ATP, 10 HEPES, 10 EGTA, and 1 Mg, pH 7.3. The bath solution was either normal Tyrode or Na-and Ca-free Tyrode. The former contained (in mM): 147 NaCl, 4 KCl, 5 HEPES, 5.5 dextrose, 2 CaCl 2, and 0.5 MgCl2, pH 7.3. The latter was made by using choline-chloride to substitute for NaCl, and MgCl2 to substitute for CaCl2.
To maximize data collection and minimize interference due to overlapping currents and issue of time-dependent I Ks run down, all of our patch-clamp recordings followed a similar time course using the same solutions and voltage-clamp protocols. Three minutes after forming the whole cell recording configuration when the intracellular dialysis with the pipette solution reached equilibrium, we recorded cell capacitance and adjusted series resistance compensation. Then, while in normal Tyrode solution, we recorded action potentials (cycle length 1 s, trains of 30 -120 pulses until the action potential morphology and duration stabilized), I CaL, IK1, and Ito. The bath solution was then switched to Na-and Ca-free solution, and we recorded the rectifier current (typically 15-20 min after the beginning of whole cell dialysis). Then 1 M dofetilide was added to the bath solution, and dofetilide-insensitive I Ks was recorded between 22 and 25 min after the beginning of whole cell dialysis. cation (densitometry with ChemiImager model 4400, Alpha-Innotech) have been described previously (27) . The cRNA concentrations were calculated based on band intensities measured by densitometry, using cRNA size markers as a reference. For coinjection, the cRNAs were mixed before injection, with molar ratio calculated by dividing the nanogram amounts of cRNAs injected by the cRNA sizes.
Oocytes were isolated as described before (57) and incubated in an ND96-based medium (in mM: 96 NaCl, 2 KCl, 2.5 pyruvate, 1.8 CaCl2, 5 HEPES, 0.5 MgCl2, pH 7.5), supplemented with 4% horse serum and penicillin/streptomycin at 16°C. Two to six hours after isolation, oocytes were injected with cRNA(s) using a Drummond digital microdispenser. Oocytes were incubated in the above medium at 16°C and studied 3-5 days after isolation. Whole oocyte membrane currents were recorded using the "2-cushion pipette" voltage-clamp method (51) . During recordings, the oocyte was continuously superfused with a low-Cl ND96 solution (replacing Cl Ϫ in ND96 with methanesulfonate) to reduce interference from endogenous Cl channels. Voltage clamp was done at room temperature (24 -26°C) with OC-725B or OC-725C amplifier (Warner Instruments). Voltageclamp protocol generation and data acquisition were controlled by pClamp5.5 via a 12-bit digital-to-analog and analog-to-digital converter (DMA, Axon Instruments). Current data were low-pass filtered at 1 kHz (Frequency Devices) and stored on disks for offline analysis.
Data Analysis
For both patch-clamp recordings from canine ventricular myocytes and two-cushion pipette voltage-clamp recordings from oocytes, the voltage-clamp protocols and methods of data analysis are described in the figure legends. The following software was used for data analysis: pClamp6 or 8, EXCEL (Microsoft), SigmaPlot, SigmaStat, and PeakFit (SPSS). Mean values with standard errors are reported here, with numbers of cells or samples studied listed in figures.
Biochemistry
Membrane-enriched fraction from canine myocardium or oocytes was made as described previously (20, 21) . Protein concentrations were measured using a Pierce kit with BSA as control. In vitro translation of KCNE1 was performed using a rabbit reticulocyte lysate system (Promega) in the presence of canine pancreatic microsomes, according to the manufacturer's instructions. To deglycosylate translated KCNE1, 1% Nonidet P-40, complete protease inhibitor cocktail, and 2 units of N-glycosidase F (Boehringer) were added to one-half (25 l) of the in vitro translation product. The mixture was incubated at 37°C for 24 h. The reaction was stopped by adding sample buffer and boiling for 2 min. A parallel control using the remaining one-half of the translation product was processed in the same manner without N-glycosidase F in the buffer.
Proteins were fractionated on 4 -20% gradient gels, blotted to polyvinylidene difluoride membranes, blocked by BSA or dry milk, and incubated with primary antibodies at 4°C overnight. The membrane was then washed and incubated with a secondary Ab. Immunoreactivity was visualized by enhanced chemiluminescence (Amersham). Residual proteins in the gels were stained with Coomassie blue (CB), and densitometry of CB stain was used to check for loading variations. For quantification of subunit expression in control vs. failing dog hearts, the subunit-specific bands were background subtracted, divided by the CB stain of the same lanes, and normalized by the mean band intensities of control hearts. The following commercial primary Abs were used: Kv4.3 (Alomone), Kv1.4 (Upstate Technology), KChIP2 (Affinity Bioreagents), and KCNQ1 (Santa Cruz Biotech). The KCNE1 Ab was a generous gift from Drs. Amber Pond and Jeanne M. Nerbonne. This Ab was raised against a peptide, [C]RV LESFRACYVI, corresponding to aa 98 -119 of mouse KCNE1, which is highly conserved across species.
Histology and Immunocytochemistry
Tissue blocks from LV free wall adjacent to where cells were isolated were embedded in parafin and cut in 10-m thin sections. The thin sections were stained by hematoxylin and eosin. Isolated myocytes (same as those for patch-clamp recordings) were fixed in 4% paraformaldehyde overnight on poly-L-lysine coated coverslips. The cells were then stored in a blocking buffer (goat serum 4% in PBS) at 4°C until the experiments. The coverslips were rinsed and incubated with anti-connexin 43 (Cx43) MAb (Chemicon) in a moisture chamber at 36°C for 2 h. The coverslips were then rinsed and incubated with Alexa 488-conjugated anti-mouse Ab for 2 h at 36°C. Immunofluorescence was visualized using a confocal laser scanning microscope (Olympus).
RESULTS
Histological Examination
For the five dogs that went through the microembolization procedures, the LVEF dropped from 60 Ϯ 5% (before microembolizations) to 28 Ϯ 7% 3 mo after the last procedure. Patchy white areas (fibrosis) were visible in the anterior and lateral LV free wall, apex, anterior part of the septum, and sometimes the anterior right ventricular free wall. Histological examination confirmed that there was diffuse interstitial fibrosis in the region of ICM hearts adjacent to where cells were isolated, often with clusters of large adipocytes (Fig. 1A) . Some regions had a high density of interstitial cells (inset of ICM panel, Fig. 1A) . Immunofluorescence of Cx43, the major gap junction channel subunit in ventricular myocardium, showed that instead of being packed in intercalated disk areas located at the ends of cells (Fig. 1B, left) , cells isolated from ICM hearts often had patches of Cx43 immunofluorescence scattered along their sides (Fig. 1B, right) . This is similar to the disarray of Cx43 distribution described for a canine model of myocardial infarction, as well as in tissue from failing human hearts (36, 37) .
Cell Capacitance and Membrane Potential Recording
Ventricular myocytes from ICM hearts had much larger cell capacitance (258 Ϯ 8 vs. 188 Ϯ 9 pF, Fig. 2B ), indicating a pronounced cellular hypertrophy. Myocytes isolated from control hearts manifested certain degree of APD variation, but the degree of APD variation became much more pronounced in myocytes from ICM hearts ( Fig. 2A, left vs. right) . On average, APD 0 mV (phase 2) was prolonged from 255 Ϯ 15 to 379 Ϯ 20 ms, and APD Ϫ60 mV (phase 3) was prolonged from 424 Ϯ 17 to 538 Ϯ 20 ms (Fig. 2B ). Under our recording conditions (controlled extra-and intracellular ionic composition), there was no difference in the RMP between the two groups of cells (Ϫ81.3 Ϯ 0.4 vs. Ϫ82.1 Ϯ 0.3 mV).
I Ks I Ks current density and voltage dependence of activation. I Ks was recorded in a nominally Na-and Ca-free bath solution (at 33-34°C) to avoid interference from Na and Ca channel currents, as well as currents mediated by the electrogenic Na/Ca exchanger. To avoid the issue of "I Ks run-down" in data interpretation, I Ks data presented here were obtained between 15 and 25 min after the beginning of whole cell dialysis. Our experience has been that I Ks amplitude in canine ventricular myocytes is relatively stable within this time window (18) , although longer intracellular dialysis inevitably leads to a decrease in I Ks . Figure 3A shows two sets of representative current traces recorded in the presence of dofetilide (1 M). After the initial spike [due to residual I to not inactivated by the holding potential (V h ) of Ϫ50 mV], there was a slowly rising outward current upon depolarization to Ϫ20 mV or more positive voltage. This was followed by a slowly decaying outward tail current upon repolarization to Ϫ50 mV. Both could be suppressed by an I Ks blocker, azimilide (18) . The slowly rising outward currents during membrane depolarization were used to construct the test pulse current-voltage relationships (after normalization by cell capacitance, Fig. 3B ), while the outward tail currents were used to construct the activation curves (Fig. 3C ). I Ks current density in ICM myocytes was reduced at voltages positive to 0 mV, but not at voltages Յ0 mV (Fig. 3B) . This voltage dependence of I Ks reduction was consistent with a modest, but statistically significant, negative shift in the voltage-dependence of I Ks activation in ICM cells relative to control cells (Fig. 3C) .
Immunoblot analysis of I Ks subunits. We used immunoblots to quantify the protein level of I Ks auxiliary subunit (KCNE1) and pore-forming subunit (KCNQ1 or Kv7.1) (6, 49) in control and ICM dog hearts. The KCNE1 Ab recognized three bands in in vitro translated proteins primed with human KCNE1 cRNA ( Fig. 4A, top) , but none in a control translation reaction without cRNA (data not shown). Treating the translation products with N-glycosidase F collapsed the upper two bands into the lowest one, whose size of 16 kDa was similar to the size of core KCNE1 (14.6 kDa). This indicates that the 24-and 20-kDa bands were likely doubly and singly glycosylated KCNE1, because the extracellular domain of KCNE1 has two N-glycosylation sites (asparagine residues at positions 5 and 26).
This KCNE1 Ab recognized a major band of ϳ20 kDa in whole tissue lysate from control dog LV, but a major band of ϳ30 kDa (as well as a weak 20-kDa band) in membraneenriched fraction from the same tissue (Fig. 4A, bottom) . This banding pattern suggests that, in canine heart, there are probably two pools of KCNE1 protein: cytoplasmic and cell surface. The cytoplasmic fraction is largely singly glycosylated (20 kDa), while the cell surface fraction is mainly doubly glycosylated (30 kDa). Fig. 4B , top, presents an immunoblot image of membrane-enriched fraction from five control dog hearts and four ICM dog hearts probed with the KCNE1 Ab. In both cases, the cell surface, doubly glycosylated fraction dominates. Densitometry of combined band intensities (after correction by CB stain of the same lanes, Fig. 4B ) showed that the KCNE1 immunoreactivity was reduced in ICM hearts to 0.63 Ϯ 0.09 (normalized by the mean intensity of control hearts, P ϭ 0.011). We and others have isolated a KCNQ1 splice variant from human heart that does not have the cytoplasmic NH 2 -terminal domain as well as the first one-third of S1, and thus cannot form functional channels on its own (11, 19) . The long (functional) isoform and the short (nonfunctional) isoform are termed KCNQ1.1 and KCNQ1.2, respectively. The KCNQ1 Ab we used (C-20, Santa Cruz) was raised against the COOHterminal domain of the protein and thus should recognize both Background and leak currents were subtracted: total current minus current after a prepulse to 0 mV that totally inactivated Ito. B: summary of peak Ito current density (pA/pF) and time constant of inactivation (in ms) measured at ϩ50 mV. *P Ͻ 0.001, ICM vs. control. C: voltage dependence of Ito inactivation. The voltage-clamp protocol is diagrammed in the inset: 2-s pulses to conditioning voltage (Vc) were applied to cause different degrees of Ito inactivation, and, after a 5-ms step to Ϫ80 mV, the degree of Ito inactivation was evaluated by the peak current amplitude measured at ϩ50 mV. The current amplitude was normalized by the maximum amplitude without Vc (availability), and the relationship between Vc and availability was fit with a Boltzmann function: availability ϭ 1/{1 ϩ exp [(Vc Ϫ V0. 6) .
Lanes 3 and 4 of Fig. 5A show that, in membrane-enriched fraction from control and ICM dog hearts, the KCNQ1 Ab recognized a 70-kDa band similar to KCNQ1.1, as well as a ϳ55-kDa band similar to KCNQ1.2. Both bands disappeared if the KCNQ1 Ab had been preincubated with the antigenic peptide (lanes 7 and 8) , suggesting that indeed these are KCNQ1-specific bands. The lower band was faint in the control heart, but was similar to the 70-kDa band in intensity in the ICM heart. Figure 5B confirms this notion. The immunoblot image of membrane-enriched fraction from two control dog hearts and two ICM dog hearts were probed with the KCNQ1 Ab. The 70-kDa band intensity was similar between the two groups, whereas the 55-kDa band was stronger and more consistent in the ICM group. These data suggest that canine ventricle expresses both KCNQ1.1 and KCNQ1.2, and the short splice variant appeared more abundant in hearts with ICM. An increase in the expression of KCNQ1.2 in ICM myocytes would suppress I Ks in a dominant-negative fashion, as has been shown in previous studies using heterologous expression systems (11, 19) .
I to I to current density and gating kinetics. I to was recorded at 33-34°C in normal Tyrode solution that contained Na and Ca ions. To avoid interference from Na and Ca channel currents, I to analysis was restricted to currents recorded at ϩ50 mV. This voltage was close to the reversal potentials of Na and Ca channels so that their influence was minimized. For current traces shown in Fig. 6A , the interference from non-I to currents was further reduced by using a conditioning step to 0 mV to totally inactivate I to , and the residual currents were subtracted from the total currents to obtained "isolated I to ". The same type of current traces was used to compare I to peak current density and time constant () of inactivation between the two groups of cells. In ICM myocytes, the I to peak current density was reduced from 18.7 Ϯ 1.7 to 11.4 Ϯ 0.9 pA/pF, while the of inactivation was modestly prolonged from 10.2 Ϯ 0.2 to 13.1 Ϯ 0.4 ms (both P Ͻ 0.001, Fig. 6B ). There was no difference in the voltage dependence of I to inactivation between the two groups of cells (Fig. 6C) . I to recovery from inactivation in canine ventricular myocytes follows a doubleexponential time course (3, 14, 26) . The recovery time course of I to in ICM myocytes appeared accelerated relative to that in control myocytes (Fig. 6D) . This difference was mainly due to an acceleration of the slow phase of recovery: the slow time constant was shortened from 1,137 Ϯ 572 to 523 Ϯ 140 ms.
Immunoblot analysis of major I to subunits. The I to channels in dog heart have two types of pore-forming subunits, Kv4.3 and Kv1. 4 , that manifest distinctly different rates of recovery from inactivation (14, 52, 57) . Kv4.3 can be modified by an association of KChIP2 auxiliary subunit in terms of current amplitude and gating kinetics (4) . We quantified these subunits' protein levels using immunoblotting on membraneenriched fraction. Figure 7A shows images of separate immunoblots loaded with the same set of membrane fraction from five control dog hearts and four ICM dog hearts. The Kv4.3, KChIP2, and Kv1.4 antibodies recognized bands of 74, 35, and 76 kDa, respectively. In one control heart, the Kv1.4 Ab also recognized a very faint 99-kDa band. The band intensities were corrected by the CB stain (not shown) and normalized by the mean band intensity from the five control hearts. Figure 7B summarizes the densitometry results. Kv4.3 showed no significant change, whereas there was a decrease in both KChIP2 and Kv1.4 in ICM vs. control, reaching a P value of Ͻ0.05.
Effects of changing the expression ratio of Kv4.3 to Kv1.4 on current properties. Kv4.3 and Kv1.4 expressed separately in oocytes exhibited similar voltage dependence of peak currentvoltage relationship as well as voltage dependence of inactivation (Fig. 8, A and B) . The rate of recovery from inactivation of Kv4.3 was 16 times faster than that of Kv1.4 (Fig. 8C ). Coexpressing the two in different ratios resulted in peak current-voltage relationship and voltage dependence of inactivation not different from those of separate expression (Fig. 8,  A and B) . However, due to the very different rates of recovery from inactivation, coexpressing Kv4.3 and Kv1.4 created a distinct biphasic recovery time course: a fast phase due to the Kv4.3 component, and a slow phase due to the Kv1.4 component (Fig. 8C) . The proportion of these two components depended on the ratio of Kv4.3/Kv1.4, so that reducing the Kv1.4 component relative to Kv4.3 produced an apparent acceleration of recovery from inactivation. Figure 9 shows that, in ICM myocytes, there was a decrease in I K1 current density in both inward and outward directions. The latter is better shown by the expanded current scale in the inset. Figure 10 shows that I CaL recorded from control and ICM myocytes were similar in the maximal peak I CaL current density (which occurred at 0 mV), time constant of the fast (major) component of inactivation, and the voltage dependence of inactivation (Fig. 10, A-C) . The rate of recovery from inactivation was tested at one voltage, Ϫ40 mV, and there was no change between the two groups of myocytes (Fig. 10D) .
I K1 and I CaL
DISCUSSION
The major findings in our study can be summarized as the following. 1) I Ks density in ventricular myocytes from dog hearts suffering ICM was reduced at voltages positive to 0 mV, reaching a 40% reduction at ϩ50 mV. This voltage-dependent I Ks reduction is consistent with a negative shift in the voltage dependence of I Ks activation. 2) KCNE1 (I Ks auxiliary subunit) was reduced in ICM vs. control hearts. Furthermore, although KCNQ1.1 (functional I Ks pore-forming subunit) was not altered in ICM hearts, a truncated nonfunctional KCNQ1.2 isoform was detected and appeared more abundant in ICM relative to control hearts. 3) I to current density measured at ϩ50 mV was reduced by 40% in ICM myocytes. There was an acceleration of I to recovery from inactivation. 4) Although Kv4.3 (pore-forming subunit of the fast-recovering I to component) was unaltered, there was a reduction in KChIP2 (auxiliary subunit of the fast-recovering I to component) and Kv1.4 (pore-forming subunit of the slow-recovering I to component). 5) I K1 current density was reduced in ICM myocytes, by 20% at Ϫ70 mV (outward component) and by 34% at Ϫ130 mV (inward component). 6) There were no changes in I CaL in ICM myocytes relative to control myocytes.
Implications for Arrhythmogenic Mechanism in the Canine Model of ICM
The mechanism of arrhythmia in this canine model of ICM has been studied previously (39) , using dogs manifesting reduced LVEF (from 63 Ϯ 3% premicroembolization, to 22 Ϯ 3%) similar to that of ICM dogs studied here. Twenty-four to 48-h Holter monitoring showed that the ICM dogs experienced premature ventricular complexes and nonsustained VT of a monomorphic or polymorphic nature. Using a three-dimensional mapping technique, the author further showed that the VT almost always arose from focal activation. Slowing of impulse conduction was rare and only occurred at sites of transmural fibrosis. There was no sign of macroreentry. The author suggested that, in this animal model, triggered activity and automaticity were the major arrhythmogenic mechanisms (39) .
The decrease in I Ks , I to , and I K1 reported here should contribute to APD prolongation in ventricular myocytes from ICM hearts (59) . It is conceivable that these myocytes suffered different degrees of K current reduction and thus had different degrees of APD prolongation, depending on their locations in the heart and their relationships to the microsphere-clogged coronary arteries. If the myocytes were well-coupled in the in situ heart, their APD would be homogenized by electrotonic interactions (38) . It is possible that the presence of interstitial fibrosis, in conjunction with the observed disarray of Cx43 subcellular distribution, might reduce the degree of intercellular coupling, allowing cells that suffered the most severe degree of K channel reduction to maintain their greatly prolonged APD. Although there was no difference in the RMP between control and ICM myocytes under our recording conditions, the decrease in I K1 predicts that membrane conductance at RMP would be reduced in the ICM cells. This could destabilize the RMP by magnifying the effects of small disturbances in membrane currents, such as transient inward currents induced by Ca i oscillation (28, 14a) , inward currents through pacemaker channels (9) , or the T-type Ca channels (15, 35) . Normal ventricular myocytes do not exhibit pacemaker currents in the physiological voltage range (43) and have little or no T-type Ca channel currents (55) . However, in ventricular myocytes from hypertrophied rat or feline hearts, an appearance of pacemaker currents and T-type Ca channel currents has been described (9, 15, 35) . Whether this occurs in the ICM dog hearts requires further experimentation. Combining these three factors (APD prolongation/increased APD dispersion, reduced electrotonic coupling, and RMP instability) would predispose the ICM hearts to arrhythmias due to triggered activity or increased automaticity. It is important to note that the effects of decreased I Ks , I to , and I K1 reported here, as well as the effects of increased long-lasting component of TTX-sensitive Na channel current reported previously (59, 62) , could have been partially offset by a simultaneous increase in I Kr in these cells (21) .
Molecular Mechanisms for I Ks and I to Remodeling in the Canine Model of ICM
Association of KCNE1 with KCNQ1.1 increases the current amplitude and shifts the voltage dependence of activation in the (60) , the effects of KCNE1 on the gating kinetics of KCNQ1.1 can be graded by the expression level of KCNE1 (7, 10) . Therefore, the decrease in KCNE1 is consistent with the negative shift in the voltage dependence of I Ks activation.
Association of KChIP2 with Kv4.3 leads to an increase in current amplitude and an acceleration of recovery from inactivation (4). Therefore, a decrease in KChIP2 is predicted to cause a reduction in I to current amplitude and a slowing of recovery from inactivation. Kv1.4 is the major molecular correlate of the slow-recovering I to component (3, 14, 57) . Therefore, a reduction in Kv1.4 could cause a decrease in I to current amplitude and an apparent acceleration of recovery from inactivation (suggested by Fig. 8C ). Therefore, reduction of both KChIP2 and Kv1.4 can contribute to the decrease in I to current density, but the decrease of the latter is responsible for the change in the rate of recovery from inactivation. Kv1.4 is more abundantly expressed in the subendocardial region (8, 61) . This, in conjunction with the lower abundance of Kv4.3 in the subendocardial region (63) , suggests that downregulation of Kv1.4 could have a larger impact on I to in the subendocardial region than the midmyocardial region studied here. Table 1 compares our findings with selected examples of other animal models of heart disease, for which remodeling of I Ks and/or I to has been described, and information on the underlying changes in channel subunit expression (at the protein level) is available (17, 41, 44, 45, 58, 63) . This comparison illustrates that an apparently similar phenotypic change (downregulation of I Ks or I to ) can have divergent molecular mechanisms. Such differences can be due to species or regional variations in the regulation of channel expression, as well as etiology and/or stages of pathological changes in the heart. These differences can lead to changes in not only current amplitude but also gating kinetics, with functional consequences in terms of arrhythmogenic mechanism and strategy for antiarrhythmic therapies.
Comparison With Previous Studies
Technical Limitations
All patch-clamp recordings were done on myocytes isolated from the mid-myocardial layer of LV free wall affected by the microembolizations. Due to the heterogeneity in ion channel expression among different regions of the heart, changes in membrane channels in other regions may differ quantitatively.
During patch-clamp recordings, the cells were dialyzed with a pipette solution containing 10 mM each of ATP, HEPES, and EGTA. These recording conditions would mask cellular abnormalities related to mitochondrial dysfunction (53) , improper handling of Ca i (14a), and other intracellular ionic perturbations. Furthermore, we stimulated the cells at a frequency of 1 Hz. Cells with plateau phase longer than 1,000 ms were excluded from our data set. Therefore, our recording conditions did not allow us to make any inference about the occurrence or prevalence of delayed afterdepolarizations or early afterdepolarizations in the ICM myocytes. Therefore, the changes we observed here likely represented intrinsic changes in membrane channels due to alterations in channel subunit expression and composition induced by the chronic ischemic process. Electrical remodeling in an in situ heart will most likely result from these "intrinsic" changes in membrane channels, with further influences by "extrinsic" changes in cellular milieu, such as ATP depletion, Ca i overload, effects of neurohumoral factors, inflammatory cytokines, reactive oxygen species, and mechanical stretch.
The Western blots were done on membrane fraction prepared from LV apex tissue. There can be differences in channel subunit expression between LV mid-myocardial layer and LV apex. Furthermore, myocardial tissue contained nonmyocyte elements. Therefore, the correlation between patch-clamp data from single isolated cells and immunoblot data from multicellular tissue is suggestive but not conclusive.
In conclusion, we suggest the following scenario. In dog hearts suffering ICM, decrease in I Ks , I to , and I K1 contributes to APD prolongation and increased APD dispersion. These differences in APD among cells in an in situ ICM heart are probably protected by reduced electrotonic coupling, due to interstitial fibrosis and disarrayed Cx43 distribution. The decrease in I K1 would also sensitize the RMP to small arrhythmogenic disturbances in membrane currents, such as transient inward currents and automaticity. These factors combined to predispose the ICM hearts to arrhythmia.
